Skip to content
★ Sign in to follow
Boji Medical Technology Co.,Ltd. logo

Boji Medical Technology Co.,Ltd. Stock: price and insider trades · China

博济医药

CN·Mcap CN¥4.6BHealth Care

Boji Medical Technology Co.,Ltd.: what insiders have been doing

This page follows insider dealings at Boji Medical Technology Co.,Ltd. as filed with SSE / SZSE (CSRC), a company from the Health Care sector. From 5 November 2025 to 5 November 2026, the disclosure feed for Boji Medical Technology Co.,Ltd. logged 1 filing by 1 insider.

No insider bought on the market over the period, while 1 insider filed 1 sale totalling €1.8M. The largest single trade was a sale of €1.8M by 横琴广金美好基金管理有限公司-广金美好费米十三号私募证券投资基金, published on 3 December 2025.

Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification.

Across the 519 companies tracked on its exchange, the median is 2 filings; at 1 filing, this issuer sits below that mark. The full history, which starts in 2021, counts no purchases against 5 sales.

For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and Vetoquinol SA. This summary is built from SSE / SZSE (CSRC) disclosures alone and does not predict where the share price will go.

Insider Decl.
5
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€4M
5 ops. · all time

Who traded when

BuySale
横琴广金美好基金管理有限公司-广金美好费米十三号私募证券投资基金1 sale

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 15,986 of 26,912 companies
45.8
score / 100
Value
41
Quality
50
FCF yld1.5%
Earn yld0.7%
EV/EBITDA·
ROE4.9%
Gross mgn27%
Net mgn3.5%
Debt/EBITDA0.7x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

CN¥11.80
Analyst consensus
·
Income statement
RevenueCN¥868.6M
Gross profitCN¥235.6M27% margin
EBITDACN¥59.9M7% margin
Net incomeCN¥30.5M5.4% margin
Valuation
PER (trailing)84.3x
P/Book4.2x
Beta0.33
Balance sheet & cash
Market capCN¥4.6B
Total debtCN¥43.8M
Free Cash FlowCN¥68.3M
Debt / Equity4%
Profitability & ownership
ROE4.9%
ROA1.0%
% insiders39.8%
% institutions1.0%
Last declaration on 3 December 2025
Declarations5 total
  • ▼
    15M CNY30SZSE
    1,707,900 shares100.0% of flowA股XSHESZSE:173000009857030400
  • ▼
    董事,高管Executives
    3M CNY9SZSE
    189,500 shares16.8% of flowA股XSHESZSE:173000009858838620
  • ▼
    董事长Executives
    4M CNY24SZSE
    288,600 shares24.2% of flowA股XSHESZSE:173000005073039400
  • ▼
    董事长Executives
    5M CNY25SZSE
    353,600 shares28.9% of flowA股XSHESZSE:173000005073039360
  • ▼
    董事长,总经理Executives
    5M CNY25SZSE
    557,000 shares30.2% of flowA股XSHESZSE:173000004826263400

5 of 5 declarations

About Boji Medical Technology Co.,Ltd.

博济医药 is a company specialized in the healthcare and pharmaceutical sector, listed on the XSHE market. It focuses on the development and commercialization of innovative drugs.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations